Dr. Yusuf Menda, MD

Dr. Menda practices at University of Iowa Health Care Medical Center in Iowa City, Iowa, part of The University of Iowa.

Dr. Menda's NPI, 1538157425, was assigned on October 13, 2005. Dr. Menda graduated from Istanbul University Fom in 1994. Dr. Menda holds Iowa license 34014.

Dr. Menda's primary practice is University of Iowa Health Care Medical Center, at 200 Hawkins Drive, Iowa City, IA 52242 in Johnson County. The practice phone is (319) 356-1616.

Dr. Menda's primary practice is University of Iowa Health Care Medical Center in Iowa City, Iowa, part of The University of Iowa. Dr. Menda is also affiliated with University of Iowa Health Care Medical Center Downtown. The medical group on file is Scanlan Center for School Mental Health Clinic. Dmand AI also links Dr. Menda to 1 more hospital, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Menda practices, 3 sites in all. Vendor and product names are available with a free account.

Nuclear medicine is Dr. Menda's primary specialty in the NPI Registry, under taxonomy code 207U00000X. Dr. Menda is board certified in nuclear medicine by the American Board of Nuclear Medicine. Dr. Menda is licensed in Iowa.

CMS data shows 324 Medicare services from Dr. Menda across 7 procedure codes in 2024, for 376 Medicare patients. Medicare paid $22,918 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 376 Medicare patients who saw Dr. Menda in 2024. The largest group is 65 to 74, with 185 patients. 75% of them have high blood pressure, and 71% have high cholesterol. 7% are also on Medicaid. Their average risk score is 2.07, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Menda's median patient age at 73, with 44% women.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 80 out of 100 for Dr. Menda for performance year 2024, reported as part of a group. Dr. Menda accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 101 papers to Dr. Menda, published from 2005 to 2024. 2020 was the busiest year, with 7. The most frequent topics are Radiopharmaceuticals, Positron-Emission Tomography and Neuroendocrine Tumors. Dr. Menda has published most often in J Nucl Med. Dr. Menda's most frequent co-authors are David L. Bushnell, MD, Parren Scott McNeely, MD and Carryn M. Anderson, MD.

Dmand AI links Dr. Menda to 11 clinical trials, 4 of them phase 2 studies. 2 are still active or recruiting. Conditions studied include Prostatic Neoplasms, Castration-Resistant, Prostatic Neoplasms and Gastro-enteropancreatic neuroendocrine tumor. Michael Graham PhD, MD sponsors the most, 3.

Dmand AI lists 1 award for Dr. Menda, most recently CMS Stage 1 EHR in 2011.

Dr. Menda graduated from Istanbul University Fom in 1994.

Dr. Menda is in network with 16 carriers, including Elevance, Blue Cross Blue Shield of Michigan and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.